Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.

There has been a large increase in basic science activity in cell therapy and a growing portfolio of cell therapy trials. However, the number of industry products available for widespread clinical use does not match this magnitude of activity. We hypothesize that the paucity of engagement with the c...

Full description

Bibliographic Details
Main Authors: Davies, B, Rikabi, S, French, A, Wartolowska, K, al., E
Format: Journal article
Language:English
Published: SAGE Publications 2014
_version_ 1797097890972172288
author Davies, B
Rikabi, S
French, A
Wartolowska, K
al., E
author_facet Davies, B
Rikabi, S
French, A
Wartolowska, K
al., E
author_sort Davies, B
collection OXFORD
description There has been a large increase in basic science activity in cell therapy and a growing portfolio of cell therapy trials. However, the number of industry products available for widespread clinical use does not match this magnitude of activity. We hypothesize that the paucity of engagement with the clinical community is a key contributor to the lack of commercially successful cell therapy products. To investigate this, we launched a pilot study to survey clinicians from five specialities and to determine what they believe to be the most significant barriers to cellular therapy clinical development and adoption. Our study shows that the main concerns among this group are cost-effectiveness, efficacy, reimbursement, and regulation. Addressing these concerns can best be achieved by ensuring that future clinical trials are conducted to adequately answer the questions of both regulators and the broader clinical community.
first_indexed 2024-03-07T05:01:46Z
format Journal article
id oxford-uuid:d881eb36-4d37-4f69-9d8e-22818dca4a69
institution University of Oxford
language English
last_indexed 2024-03-07T05:01:46Z
publishDate 2014
publisher SAGE Publications
record_format dspace
spelling oxford-uuid:d881eb36-4d37-4f69-9d8e-22818dca4a692022-03-27T08:49:18ZQuantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d881eb36-4d37-4f69-9d8e-22818dca4a69EnglishSymplectic Elements at OxfordSAGE Publications2014Davies, BRikabi, SFrench, AWartolowska, Kal., EThere has been a large increase in basic science activity in cell therapy and a growing portfolio of cell therapy trials. However, the number of industry products available for widespread clinical use does not match this magnitude of activity. We hypothesize that the paucity of engagement with the clinical community is a key contributor to the lack of commercially successful cell therapy products. To investigate this, we launched a pilot study to survey clinicians from five specialities and to determine what they believe to be the most significant barriers to cellular therapy clinical development and adoption. Our study shows that the main concerns among this group are cost-effectiveness, efficacy, reimbursement, and regulation. Addressing these concerns can best be achieved by ensuring that future clinical trials are conducted to adequately answer the questions of both regulators and the broader clinical community.
spellingShingle Davies, B
Rikabi, S
French, A
Wartolowska, K
al., E
Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.
title Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.
title_full Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.
title_fullStr Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.
title_full_unstemmed Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.
title_short Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot study.
title_sort quantitative assessment of barriers to the clinical development and adoption of cellular therapies a pilot study
work_keys_str_mv AT daviesb quantitativeassessmentofbarrierstotheclinicaldevelopmentandadoptionofcellulartherapiesapilotstudy
AT rikabis quantitativeassessmentofbarrierstotheclinicaldevelopmentandadoptionofcellulartherapiesapilotstudy
AT frencha quantitativeassessmentofbarrierstotheclinicaldevelopmentandadoptionofcellulartherapiesapilotstudy
AT wartolowskak quantitativeassessmentofbarrierstotheclinicaldevelopmentandadoptionofcellulartherapiesapilotstudy
AT ale quantitativeassessmentofbarrierstotheclinicaldevelopmentandadoptionofcellulartherapiesapilotstudy